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ABSTRACT
Objective: A comparative study of anti-prostate agents to investigate the stereochemical influences on binding affinity by molecular docking.
Methods: Structures of enantiomers (R and S stereoisomers) for known anti-prostate cancer (PCa) agents were drawn using ChemBioDraw 2D 
software. Thereafter, they were converted to 3D structures using the ChemBioDraw 3D software in which they were subjected to energy minimization 
using the MM2 method and then saved as PDB extension files which can be accessed using the ADT interface. AutoDock Vina (ADT) 1.5.6 software 
version was used for molecular docking study.
Results: A total of 12 different anti-PCa agents were selected and drawn including well-known drug R-bicalutamide. All molecules showed the binding 
affinity with respect to the nature of stereochemistry. R-stereoisomers showed better interaction as well as binding affinity toward 1z95 (mutated 
androgen receptor protein involved in the progression of PCa) whereas their S-stereoisomers were found inferior in comparison.
Conclusion: This study showed that CB1-R and R-bicalutamide (with R-stereochemistry) were better in binding affinity comparative to their 
counterpart CB1-S and S-Bicalutamide (with S-stereochemistry). All the selected anti-PCa agents were showing the effect of stereochemical center; 
therefore, we must choose the right kind of stereochemistry while planning to develop the newer anti-PCa agents.
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INTRODUCTION
Prostate cancer (PCa) has been described as a disease that affects the 
prostate region of the male genital organ due to the proliferation of 
androgen receptors and hormones present in the prostate organ [1]. 
Research shows in the preventive medicine reports that PCa continues 
to disproportionately affect African-American men in terms of 
mobility and mortality [2]. Furthermore, various examination studies, 
knowledge, beliefs, and behaviors on PCa screening [3] and recent 
researches also evaluate the effect of interventions that focus on 
enhancing the screening and about decision-making among African-
American men [4,5].
As described and illustrated earlier, PCa is a leading cause of death in 
men. Globally, it is the most diagnosed/screened among men AutoDock 
Vina between the ages of 65 and 74 years [2]. The prediction or 
diagnosis differs greatly, but highly dependent on a number of factors 
such as stage of diagnosis, race, and age. Currently, the treatment of PCa 
includes androgen deprivation, surgery, radiation, endocrine therapy, 
radical prostatectomy, and chemotherapy [6]. Drugs like flutamide 
(Eulexin), hydroxyflutamide (Active form of flutamide), bicalutamide 
(Casodex), nilutamide, and enzalutamide (formerly called MDV3100) 
(Xtomdi) are all non-steroidal androgen receptor antagonists which 
were approved for the treatment of PCa [7].
Recent years, stereochemistry has gained great attention in 
pharmaceutical industries and regulatory authorities [8]. 
Stereochemistry is mostly dealt with compounds which possess chiral 
centers. Chiral compounds which are not superimposable in their 
mirror images are known as enantiomers and have opposite rotation 
of the direction of plane polarized light. R and S stereoisomers are the 
enantiomers represent the absolute stereochemistry of stereocenter 
in 3D structure. These enantiomers behave differently in interaction 
with chiral environments such as enzymes, receptors, and transporters. 
Generally, they differ in chemical and pharmacological properties 
such as bioavailability, the rate of metabolism, metabolites, excretion, 
potency, and selectivity for receptors, enzymes, and transporters [9]. 
50% of marketed drugs are chiral and out of that 50% are available as 
racemate (an equal mixture of both enantiomers) mixtures [10]. The 
most important thing here is that these two enantiomers may have 
same pharmacological action, for example, ofloxacin (R-enantiomer) 
and levofloxacin (S-enantiomer) which are both antimicrobials of 
quinolones [11]. One enantiomer may be active and the other may 
be inactive, the examples are (S)-albuterol, a β2-adrenergic receptor 
agonist for treatment of asthma, and (S)-omeprazole, a proton pump 
inhibitor for treatment of gastroesophageal reflux has been shown to 
be superior to their racemic formulations in clinical trials cause their 
R-enantiomers are inactive [9]. One of them may be having some 
undesirable effects, like S-timolol, a β-blocker agent can cause severe 
bronchoconstriction, while R-isomer did not cause, due to this it is 
marketed as pure R-enantiomer [12]. Hence, to achieve better results 
in therapy and prevent harmful effects of unwanted enantiomer, 
the availability and isolation of a single enantiomer have become an 
important issue in pharmaceuticals, nowadays.
METHODS
Computer-aided drug design, especially molecular docking, is a very 
useful method to find out the potent molecule without investing extreme 
effort along with funds in research [13-17]. ADT 1.5.6 software [18] is 
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used by us to examine the activity in terms of binding affinity (Kcal/
mol), and thereafter, the outcomes were compared in binding affinity 
score for best-docked conformation. The structures of various known 
anti-PCa agents were drawn with their stereochemistry with the help 
of ChemBiodraw ultra and further converted to the 3D structure using 
ChemBiodraw 3D. All the designed structures were optimized by energy 
minimization using MM2 method [19] and converted to readable 
format at the ADT interface. For a comparative study of stereoisomers 
of the anti-PCa agents, a protein 1z95 was selected and downloaded 
from protein data bank [20]. The outcomes of results were analyzed 
by AutoDock Vina (ADT) result which reveals close contact, hydrogen 
bond, hydrophilic, and hydrophobic interactions.
RESULTS AND DISCUSSION
The main purpose of this study is to find out the stereochemical effect 
of anti-PCa agents which are used the treatment of PCa or recently 
investigated. The molecules were selected from the available literature 
having a different class of compounds, that is, bicalutamide [21], 
propionamides [22], and thioxoimidazolidinones [23] as shown in 
Fig. 1.
All structures were drawn through ChemBioDraw 2D software (both 
R and S or RR and SS) to study the stereochemical effect and then 
converted into 3D structures using ChemBioDraw 3D software an 
later saved as pdb files so that it can be accessed by the ADT software. 
Androgen protein receptor was downloaded from the protein data bank 
site rcsb.org specifically protein with code 1z95 for this study.
All the selected molecules were analyzed using the ADT molecular 
modeling software. Initially, the protein validation has been done by 
extraction of ligand (Fig. 2). Preparations of ligands were done by 
the addition of polar hydrogens, detecting root, and converting it to 
pdbqt extension file, while 1z95 protein was prepared by removing 
water molecules, repairing missing atoms, adding polar hydrogens 
only, and subsequently adding the Kollman charges. Further, the 
grid box was generated keeping the ligand as a center (Fig. 3). From 
grid output file, the configuration file “conf.txt” was prepared and 
command prompt was used for ADT molecular docking by giving the 
command “program files\the scripps research institute\vina\vina.
exe --config conf.txt --log log.txt.” It generated the output file with 
the docking score or binding affinity (Kcal/mol). Similarly, all twelve 
molecules were studied and their binding affinities are shown in 
Table 1.
The study was based on twelve different molecules containing one or 
more stereocenter. Binding affinities represented in Table 1 revealed 
that stereochemistry played a critical role and considered for better 
interaction with the 1z95 protein. This was observed while comparison 
of the binding affinities of all R-stereoisomers with their S-stereoisomers. 
To know the effect of stereochemistry and various substituents, all the 
interactions of protein 1z95 were analyzed in detail. Different amino 
acid residues are found to be involved in the interactions at binding 
sites include ILE899, ASN705, LEU704, THR877, ARG752, MET745, 
MET895, GLN711, and LEU741. The aforementioned amino acids can be 
classified on the basis of their polarity, hydrophobicity, and charge such 
as ILE899, LEU704, MET745, MET895, and LEU741 are hydrophobic 
in nature, while ASN705, THR877, and GLN711 are polar amino acids 
present in the protein receptor 1z95, therefore, represent similar kind 
of interaction with the molecule of interest.
Both R or RR and S or SS were studied for their interactions with the 
1z95 protein. These results suggested the essence of stereocenter 
on the binding affinity of the existing anti-PCa agents. In Table 1, 
all propanamide and thioxoimidazolidinone derivatives having 
R and R,R stereocenter showed more binding affinity than the S 
and S,S stereocenter ligands. Among them, molecules with higher 
binding affinity were discussed herein in detail. Molecule CA1-R 
(R-bicalutamide) and CA1-S (S-bicalutamide) were found to be with 
−11.3 Kcal/mol and −10.3 Kcal/mol binding affinity, respectively, to 
1z95 protein.
Fig. 1: Selected anti-prostate cancer agents for the comparative 
study of stereochemical effect
Fig. 2: Extracted and preparation of ligand from 1z95 protein
Fig. 3: Set grid box on 1z95 protein as a macromolecule
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Fig 4: Interactions between ligand CA1-R (R-stereoisomer) and protein 1z95
Fig. 5: Interactions between ligand CA1-S (S-stereoisomer) and protein 1z95
Fig. 6: (a) Ligand CA1-R (R-stereoisomer) and (b) CA1-S (S-stereoisomer) with ribbon structure of protein 1z95
a b
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Fig. 7: Overlay of ligands CA1-R (R-stereoisomer) and CA1-S 
(S-stereoisomer) with their binding affinity
Table 1: Selected ligands with affinity





































of CA1-R (R-bicalutamide), similar interaction showed by cyano group 
with MTH745 and GLU711. The carbonyl group of the ASN705 residue 
of the 1z95 is involved in a hydrogen bonding with the chiral hydroxyl 
group and sulphone group of CA1-R (R-bicalutamide). The interactions 
between the protein (1z95) and ligand CA1-S (S-bicalutamide) are 
less favorable (Figs. 5 and 6). Herein, also amine group of the ARG752 
residue of the receptor protein is involved in hydrogen bonding with 
the cyano group of CA1-S (S-bicalutamide), while chiral hydroxyl group 
does not involve in hydrogen bonding resulting in low binding affinity. 
The overlay of CA1-S (S-bicalutamide) and CA1-R (R-bicalutamide) 
depicted in Fig. 7 showed the importance of chiral hydroxyl group 
which is opposite in case of CA1-S (S-bicalutamide), therefore, lacking 
hydrogen bonding and resulting low binding affinity.
CONCLUSION
The evolution of PCa occurs as a result of the overexpression of 
androgen receptor. There are several therapies available to treat PCa, 
but the most commonly used is chemotherapy include non-steroidal 
drugs. These drug molecules have a good involvement of hydroxyl group 
with particular stereochemistry. Thus, the present study is undertaken 
to investigate the role of the stereochemistry of bicalutamide, 
propanamide, and thioxoimidazolidinones as anti-PCa agents.
ADT molecular software was used for molecular docking of all 
stereoisomers on 1z95 (Androgen receptor) protein. Binding affinities 
revealed that molecule with score shows that R-stereochemistry is very 
important at the binding site resulting in higher binding affinity than its 
S-stereoisomer. Therefore, it could be suggested that while designing 
the novel anti-PCa agents, we must consider the stereochemistry at the 
stereocenter.
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